— Know what they know.
Not Investment Advice

FNA NYSE

Paragon 28, Inc.
1W: +0.5% 1M: +0.5% 3M: +22.8% 1Y: +35.8% 3Y: -18.4%
$13.09
Last traded 2025-04-17 — delisted
NYSE · Healthcare · Medical - Devices · $1.1B mcap · 44M float · 5.82% daily turnover · Short 56% of daily vol

Revenue Segmentation

By Geography

Income Trends

Revenue
$256M +18.4% ▲
5Y CAGR: +19.2%
Gross Profit
$191M +16.5% ▲
5Y CAGR: +17.0%
Operating Income
-$41M +10.7% ▲
Net Income
-$55M +5.0% ▲
EPS (Diluted)
$-0.66 +5.7% ▲
EBITDA
-$23M +36.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$111M$147M$181M$216M$256M
YoY Growth+4.4%+32.9%+23.0%+19.3%+18.4%
Cost of Revenue$25M$28M$32M$52M$65M
Gross Profit$86M$119M$149M$164M$191M
Gross Margin77.4%81.0%82.1%76.0%74.7%
R&D Expenses$11M$16M$25M$30M$27M
SG&A Expenses$73M$114M$159M$180M$205M
Operating Expenses$84M$130M$184M$210M$232M
Operating Income$6M-$11M-$35M-$46M-$41M
Operating Margin5.1%-7.3%-19.3%-21.1%-15.9%
Interest Expense$602K$2M$4M$5M$12M
Income Before Tax$5M-$13M-$67M-$57M-$53M
Tax Expense$2M$713K-$64K$213K$1M
Net Income$3M-$14M-$67M-$58M-$55M
Net Margin2.4%-9.3%-37.1%-26.6%-21.3%
EPS (Diluted)$0.04$-0.18$-0.88$-0.70$-0.66
EBITDA$12M-$2M-$48M-$37M-$23M
Shares Outstanding76M76M77M82M83M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms